Outbreaks of COVID-19 are accompanied by immunocompromised through hyperexpression of both proinflammatory (IL-1, IL-2, IL-6, and TNF-α) and anti-inflammatory (IL-4, IL-10, and IL-17) cytokines, and vice versa with IFN-γ. The gene discussed is IL17A; the disease is COVID-19.